During longitudinal MRD assessments in pediatric B-ALL patients, we observed that isolated CLCs (CD19(+)/TdT(+)) showed different immunophenotypes based on their CD10/CD34 status. The gene discussed is CD34; the disease is precursor B-cell acute lymphoblastic leukemia.